Home Compliance DOJ Filing Reawakens Fraud-On-The-FDA Theory Of Liability ComplianceExpert OpinionFCANews DOJ Filing Reawakens Fraud-On-The-FDA Theory Of Liability August 24, 2022 34 Share FacebookLinkedinTwitter kenary820 | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Compliance DOJ Implementation and Enforcement Plans for the Sensitive Data Executive Order—What It Means for Organizations Compliance Scope and Impact of the FTC’s Non-Compete Rule for Employers Compliance CISA Unveils Final Self-Attestation Form for Software Producers Bidding on Federal Contracts